Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 15/20 | 1.00 |
| ▸ | PDE4B | Q07343 | 15/20 | 1.00 |
| ▸ | PDE4C | Q08493 | 15/20 | 1.00 |
| ▸ | PDE4D | Q08499 | 15/20 | 1.00 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.45 |
| ▸ | KHK | P50053 | 1/20 | 0.45 |
| ▸ | HTR6 | P50406 | 1/20 | 0.44 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29824397 | 1.00 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DACHE | |
| SCHEMBL291798 | 0.98 | PDE4A (0.96) | PDE4APDE4BPDE4CPDE4DACHE | |
| SCHEMBL10713846 | 0.91 | PDE4A (0.84) | PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL10705672 | 0.91 | PDE4A (0.84) | PDE4APDE4BPDE4CPDE4DACHE | |
| SCHEMBL10707518 | 0.90 | PDE4A (0.81) | PDE4APDE4BPDE4CPDE4DACHE | |
| SCHEMBL3539405 | 0.85 | PDE4A (0.75) | PDE4APDE4BPDE4CPDE4DACHE | |
| SCHEMBL5201775 | 0.85 | PDE4A (0.86) | PDE4APDE4BPDE4CPDE4DACHE | |
| SCHEMBL3538019 | 0.85 | PDE4A (0.75) | PDE4APDE4BPDE4CPDE4DACHE | |
| SCHEMBL11013543 | 0.84 | PDE4A (0.72) | PDE4APDE4BPDE4CPDE4DACHE | |
| SCHEMBL10705322 | 0.83 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240316015-A1 | COMPOSITION AND METHOD FOR TREATING TUMORS | NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD. (CN) | 2024-09-26 | — | — | US | claimed |
| EP-4282413-A1 | COMPOSITION AND METHOD FOR TREATING TUMORS | NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD. (CN) | 2023-11-29 | — | — | EP | claimed |
| CN-116963773-A | Compositions and methods for treating tumors | 浙江养生堂天然药物研究所有限公司 | 2023-10-27 | — | — | CN | claimed |
| US-20230338345-A1 | DRUG COMBINATION AND USE THEREOF | NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD. (CN) | 2023-10-26 | — | — | US | claimed |
| EP-4074805-B1 | WOOD MATERIAL AND BINDER COMPOSITION AND METHOD FOR PRODUCING A WOOD MATERIAL | SWISS KRONO Tec AG (CH) | 2023-07-26 | — | — | EP | claimed |
| EP-3370294-B1 | SECONDARY BATTERY AND PREPARATION METHOD THEREFOR | REAL POWER INDUSTRIAL LTD COMPANY (CN) | 2023-06-28 | — | — | EP | claimed |
| EP-3315486-B1 | METHOD FOR PRODUCING AROMATIC COMPOUND | TOSOH CORP (JP) | 2023-06-07 | — | — | EP | claimed |
| EP-4153556-A1 | METHOD FOR PREPARING ACRYLIC ACID FROM BETA-PROPIOLACTONE | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2023-03-29 | — | — | EP | claimed |
| EP-3191431-B1 | MICRONUTRIENT FERTILIZER | SUN CHEMICAL CORP (US) | 2023-03-08 | — | — | EP | claimed |
| EP-4140480-A1 | DRUG COMBINATION AND USE THEREOF | NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD. (CN) | 2023-03-01 | — | — | EP | claimed |
| WO-2003051344-A1 | METHODS OF INDUCING OVULATION_USING A NON-POLYPEPTIDE CAMP LEVEL MODULATOR | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 2003-06-26 | — | — | WO | claimed |
| US-20020103106-A1 | Methods of inducing ovulation | MERCK SERONO SA (CH) | 2002-08-01 | — | — | US | claimed |
| EP-0770872-B1 | Method for the determination of specific gravity of fluids | BAYER AG (US) | 2001-01-31 | — | — | EP | claimed |
| EP-0941256-B1 | METHOD FOR PREPARING POLYACRYL(METH)ACRYLATES | BASF AG (DE) | 2001-01-24 | — | — | EP | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0745613-B1 | Synthesis of silyl-functional telechelic hydrocarbon polymers | DOW CORNING (US) | 1998-10-14 | — | — | EP | claimed |
| EP-0510625-B1 | Process for preparing hindered amine light stabilizers | MONTELL NORTH AMERICA INC (US) | 1997-07-02 | — | — | EP | claimed |
| EP-0469331-B1 | Process for preparing organic esters and amides and catalyst system therefor | MONTELL NORTH AMERICA INC (US) | 1996-09-11 | — | — | EP | claimed |
| EP-0125554-B1 | ION TEST MEANS HAVING A HYDROPHILIC CARRIER MATRIX | MILES INC. (US) | 1988-07-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240316015-A1 | COMPOSITION AND METHOD FOR TREATING TUMORS | PDE4B, PDE4A, PDE4C | PDE4A 2/4885PDE4B 1/4885PDE4C 3/4885 |
| US-20230338345-A1 | DRUG COMBINATION AND USE THEREOF | PDE4B, PDE4A, ADH4 | PDE4A 2/4885PDE4B 1/4885PDE4C 10/4885 |
| US-20020103106-A1 | Methods of inducing ovulation | PDE4A, PDE4B, PDE4C | PDE4A 1/4885PDE4B 2/4885PDE4C 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.